Capricor Therapeutics | CAPR - Equity Capital And Reserves


Capricor Therapeutics reported $305.79M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
Bioline Rx USD 19.53M 537K Sep/2025
Capricor Therapeutics USD 305.79M 221.92M Dec/2025
Cipla INR 329.19B 16.3B Sep/2025
Cytokinetics USD -826.57M 166.94M Mar/2026
Geron USD 225.87M 22.83M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD -6.67M 17.17M Dec/2025
J&J USD 81.19B 358M Mar/2026
Plus Therapeutics USD 4M 1.06M Dec/2025
Prothena USD 280.47M 14.51M Dec/2025
PTC Therapeutics USD -205.31M 49.56M Dec/2025
Sarepta Therapeutics USD 1.14B 179.5M Dec/2025